Prothena Corporation plc (0Y3M.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
60.65-3.86 (-5.98%)
At close: 5:25PM BST
| Previous close | 64.51 |
| Open | 60.65 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 60.65 - 60.65 |
| 52-week range | 60.65 - 60.65 |
| Volume | 1 |
| Avg. volume | N/A |
| Market cap | 1.979B |
| Beta (5Y monthly) | 1.45 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.71 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Prothena (PRTA) Riding High on Alzheimer's Disease Pipeline
Prothena (PRTA) has promising candidates for Alzheimer's disease in its pipeline. The successful development of the candidates will be a big boost for the company.
- Zacks
VRTX vs. PRTA: Which Stock Should Value Investors Buy Now?
VRTX vs. PRTA: Which Stock Is the Better Value Option?
- Zacks
Roche's (RHHBY) AD Drug Gets Breakthrough Therapy Status
Roche (RHHBY) gets Breakthrough Therapy Designation for gantenerumab for Alzheime's disease, which puts the spotlight on this challenging but promising space.
© 2021 Verizon Media. All rights reserved.
